They investigated the effect of GLP1 treatment on T2D and IR rats, and found that following GLP1 treatment, the OPG/RANKL ratio was increased in T2D and IR rats as compared to normal rats. The gene discussed is TNFRSF11B; the disease is type 2 diabetes mellitus.